CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia.
Journal articles
- Journal Article
Kumar, A; Goldberg, A; Alder, L; Hamparsumian, A
Published in: J Natl Compr Canc Netw
March 31, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 31, 2026
Volume
24
Issue
3.5
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, A., Goldberg, A., Alder, L., & Hamparsumian, A. (2026). CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. J Natl Compr Canc Netw, 24(3.5). https://doi.org/10.6004/jnccn.2025.7370
Kumar, Anivarya, Amit Goldberg, Laura Alder, and Anahid Hamparsumian. “CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia.” J Natl Compr Canc Netw 24, no. 3.5 (March 31, 2026). https://doi.org/10.6004/jnccn.2025.7370.
Kumar A, Goldberg A, Alder L, Hamparsumian A. CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. J Natl Compr Canc Netw. 2026 Mar 31;24(3.5).
Kumar, Anivarya, et al. “CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia.” J Natl Compr Canc Netw, vol. 24, no. 3.5, Mar. 2026. Pubmed, doi:10.6004/jnccn.2025.7370.
Kumar A, Goldberg A, Alder L, Hamparsumian A. CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. J Natl Compr Canc Netw. 2026 Mar 31;24(3.5).
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 31, 2026
Volume
24
Issue
3.5
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis